Search

everythinglearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Anti-CD19 therapy may help treat SLE and NMOSD.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

The skin plays a key role in immune responses and reflects emotional and stress reactions.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Microneedles can precisely deliver cancer treatments with fewer side effects.

Fibroblast and immune cell interactions affect tissue repair and fibrosis.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Avian yolk antibodies offer a promising, ethical alternative for disease prevention and therapy.

Targeted immune modulation can help achieve stable remission in alopecia areata.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.